| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | Nov 28, 2025 | NEOGENOMICS INC | EVP, GC & Business Development | Sell | 7.5 | -20,916 | -40.22% | ✓ | $251K |
| Oct 16, 2025 | Oct 20, 2025 | NEOGENOMICS INC | EVP, GC & Business Development | Sell | 28.8 | -4,918 | -10.26% | ✓ | $49.2K |
| May 11, 2024 | Dec 4, 2024 | NEOGENOMICS INC | General Counsel | Sell | 46.3 | -1,584 | -3.86% | ✗ | $23.5K |
| Nov 15, 2024 | Nov 19, 2024 | NEOGENOMICS INC | General Counsel | Sell | 25.0 | -5,175 | -12.23% | ✓ | $79.5K |
| Aug 15, 2024 | Aug 19, 2024 | NEOGENOMICS INC | General Counsel | Sell | 45.0 | -1,040 | -2.32% | ✓ | $16.7K |
| May 15, 2024 | May 17, 2024 | NEOGENOMICS INC | General Counsel | Sell | 26.3 | -1,049 | -2.28% | ✗ | $16.5K |
| May 11, 2024 | May 14, 2024 | NEOGENOMICS INC | General Counsel | Sell | 46.3 | -1,584 | -3.86% | ✗ | $23.5K |
| Feb 15, 2024 | Feb 20, 2024 | NEOGENOMICS INC | General Counsel | Sell | 26.3 | -2,587 | -6.91% | ✗ | $38.7K |
| Nov 17, 2023 | Nov 20, 2023 | NEOGENOMICS INC | General Counsel | Sell | 26.3 | -2,669 | -6.70% | ✗ | $49.1K |